Wellspring Biosciences, Inc.
http://www.wellspringbiosciences.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Wellspring Biosciences, Inc.
Kura Continues Araxes Legacy With New Menin And FTI Focuses In Cancer
Emerging Company Profile: The US biotech is advancing a pipeline of precision medicines targeting menin and farnesyltransferase for liquid and solid tumors, respectively, building on the work of two pioneering companies in the KRAS space.
Oncology’s Hold Over The Pharma Pipeline Increases As Growth Slows
The rate of growth of the pharma pipeline slowed last year as oncology and rare diseases tightened their grip on R&D. There are also further signs of China’s rise in importance in the industry.
FDA Urges Caution in Some Neurovascular Stent Use
US FDA has issued new guidelines to providers because some patients experienced strokes or died after being treated for unruptured brain aneurysms with some neurovascular stents.
ISC 2018: ARISE II Supports J&J's EmboTrap Stent-Retriever
The International Stroke Conference in Los Angeles featured new data that will support an FDA submission for J&J/Cerenovous' EmboTrap revascularization device. The findings showed a high rate of "first-pass" effectiveness and EmboTrap was successful in creating final substantial reperfusion in 90% of the treated patients.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Araxes Pharma LLC
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice